1-9 of 9
Pier Giorgio Natali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy

Free
Michele Maio, Alessia Covre, Elisabetta Fratta, Anna Maria Di Giacomo, Pietro Taverna, Pier Giorgio Natali, Sandra Coral, Luca Sigalotti
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4040–4047.
https://doi.org/10.1158/1078-0432.CCR-14-2914
Published: 14 September 2015
View articletitled, Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
Open the PDF for Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy in another window
Journal Articles

Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

Free
Laura Rosanò, Roberta Cianfrocca, Francesca Spinella, Valeriana Di Castro, Maria Rita Nicotra, Alessandro Lucidi, Gabriella Ferrandina, Pier Giorgio Natali, Anna Bagnato
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2350–2360.
https://doi.org/10.1158/1078-0432.CCR-10-2325
Published: 14 April 2011
View articletitled, Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
Open the PDF for Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells in another window
Includes: Supplementary data
Journal Articles

Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines

Free
Maria S. Pino, Michele Balsamo, Francesca Di Modugno, Marcella Mottolese, Massimo Alessio, Elisa Melucci, Michele Milella, David J. McConkey, Ulrike Philippar, Frank B. Gertler, Pier Giorgio Natali, Paola Nisticò
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4943–4950.
https://doi.org/10.1158/1078-0432.CCR-08-0436
Published: 01 August 2008
View articletitled, Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines
Open the PDF for Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines in another window
Journal Articles

The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors

Free
Francesca Di Modugno, Marcella Mottolese, Anna Di Benedetto, Andrea Conidi, Flavia Novelli, Letizia Perracchio, Irene Venturo, Claudio Botti, Elke Jager, Angela Santoni, Pier Giorgio Natali, Paola Nisticò
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1470–1478.
https://doi.org/10.1158/1078-0432.CCR-05-2027
Published: 06 March 2006
View articletitled, The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors
Open the PDF for The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors in another window
Includes: Supplementary data
Journal Articles

Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress

Free
Alfonso Baldi, Daniela Lombardi, Patrizia Russo, Emanuele Palescandolo, Antonio De Luca, Daniele Santini, Feliciano Baldi, Luigi Rossiello, Maria Lucia Dell'Anna, Arianna Mastrofrancesco, Vittoria Maresca, Enrica Flori, Pier Giorgio Natali, Mauro Picardo, Marco G. Paggi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3175–3183.
https://doi.org/10.1158/1078-0432.CCR-04-0631
Published: 02 May 2005
View articletitled, Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress
Open the PDF for Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress in another window
Journal Articles

Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors

Free
Stefania Uccini, Olga Mannarino, Heather P. McDowell, Ursula Pauser, Roberta Vitali, Pier Giorgio Natali, Pierluigi Altavista, Tiziana Andreano, Simona Coco, Renata Boldrini, Sandro Bosco, Anna Clerico, Denis Cozzi, Alberto Donfrancesco, Alessandro Inserra, George Kokai, Paul D. Losty, Maria R. Nicotra, Giuseppe Raschellà, Gian Paolo Tonini, Carlo Dominici
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 380–389.
https://doi.org/10.1158/1078-0432.380.11.1
Published: 21 January 2005
View articletitled, Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors
Open the PDF for Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors in another window
Journal Articles

Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells

Free
Francesca Spinella, Laura Rosanò, Valeriana Di Castro, Maria Rita Nicotra, Pier Giorgio Natali, Anna Bagnato
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4670–4679.
https://doi.org/10.1158/1078-0432.CCR-04-0315
Published: 21 July 2004
View articletitled, Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells
Open the PDF for Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells in another window
Journal Articles

Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy

Free
Claudio Botti, Simonetta Buglioni, Maria Benevolo, Diana Giannarelli, Paola Papaldo, Francesco Cognetti, Patrizia Vici, Franco Di Filippo, Franca Del Nonno, Franco Maria Venanzi, Pier Giorgio Natali, Marcella Mottolese
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1360–1365.
https://doi.org/10.1158/1078-0432.CCR-1092-03
Published: 20 February 2004
View articletitled, Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy
Open the PDF for Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy in another window
Journal Articles

Endoglin Is a Suitable Target for Efficient Imaging of Solid Tumors: In Vivo Evidence in a Canine Mammary Carcinoma Model

Free
Ester Fonsatti, Antti P. Jekunen, Kalevi J. A. Kairemo, Sandra Coral, Marjatta Snellman, Maria Rita Nicotra, Pier Giorgio Natali, Maresa Altomonte, Michele Maio
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 2037–2043.
Published: 01 May 2000
View articletitled, Endoglin Is a Suitable Target for Efficient Imaging of Solid Tumors: In Vivo Evidence in a Canine Mammary Carcinoma Model
Open the PDF for Endoglin Is a Suitable Target for Efficient Imaging of Solid Tumors: In Vivo Evidence in a Canine Mammary Carcinoma Model in another window